Published in Cancer Weekly, February 24th, 1997
The data were announced at the Therapeutic Transgenics Conference, held in West Palm Beach, Florida, where the company also announced that it has demonstrated high-efficiency purification results in a second monoclonal antibody, using a process that has broad application to other antibodies.
The expression results and verification of binding quality...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.